21 April 2011
Embryonic stem cells, induced pluripotent cells, transdifferentiated cells – there is now a wide range of options for medical researchers trying to regenerate disease-affected tissues and organs. But which approach will win the day, and can science policy keep up with the bioethical implications of rapid progress?
View Journal Article / Working PaperDr Paul Fairchild and his team from the Oxford Stem Cell Institute are featured in an academic paper in Current Biology.
Turning a groundswell of climate action into ground rules for net zero
Challenges and opportunities in translating ethical AI principles into practice for children
High Molar Mass Polycarbonates as Closed-Loop Recyclable Thermoplastics
Accelerating carbon neutrality in China: Sensitive intervention points for the energy and transport sectors in Beijing and Hong Kong
School to work transition: Employment and expectations of former madrasa students in Cox’s Bazar, Bangladesh
Prosocial preferences improve climate risk management in subsistence farming communities
If you found this page useful, sign up to our monthly digest of the latest news and events
Subscribe